Mercy BioAnalytics logo

Mercy BioAnalytics Funding & Investors

Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.It has developed a process that uses nano-particles that are extraordinarily abundant in blood and carry information about their parent cell - known as extracellular... Read more

mercybio.com

Total Amount Raised: $68,277,696

Mercy BioAnalytics Funding Rounds

  • Series A

    $41,000,000

    Series A Investors

    Hatteras Venture Partners
    Broadway Angels
    Novalis LifeSciences
    LabCorp
    Sozo Ventures
    iSelect Fund
    Bruker
    American Cancer Society
  • Undisclosed

    $27,277,694

    Undisclosed Investors

    The Perkins Fund
Funding info provided by Diffbot.